Forest Ray PhD

Forest Ray received his PhD in systems biology from Columbia University, where he developed tools to match drug side effects to other diseases. He has since worked as a journalist and science writer, covering topics from rare diseases to the intersection between environmental science and social justice. He currently lives in Long Beach, California.

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.

Articles by Forest Ray PhD

March 11, 2021 News by Forest Ray PhD

Forest Ray PhD

Articles by Forest Ray PhD

Proposed Anti-inflammatory Treatment Found Non-toxic in Zebrafish

Emerald Health Preparing for Phase 2 Trial of EHP-101 for Relapsing MS

NeurologyLive, CMSC Launch Expert Video Series ‘Cure Connections’

Pipeline Testing PIPE-307 Remyelinating Compound in Healthy Volunteers

#ACTRIMS2021 – Benign Versus Aggressive MS – the Hunt for Clues

#ACTRIMS2021 – Cognitive, Without Physical, Disability Growing Concern in MS

#ACTRIMS2021 – COVID-19 Vaccines Safe for MS Patients, Minimally Affected by DMTs

#ACTRIMS2021 -MS Demographics in Latin America Broadly Similar to US, Europe

#ACTRIMS2021 – Realities and Challenges of MS in Latin America

#ACTRIMS2021 – 30 Minutes in Sun Each Day Lowers MS Risk in Children

#ACTRIMS2021 – Research Examines T-cells’ Anti-inflammatory Potential

#ACTRIMS2021 – Blood NFL Levels Seen to Rise With Markers of MS Progression

Pipeline Raises $80M to Pursue Potential Myelin Restoring Therapy

Trial to Examine if Ocrevus Eases Cognitive Fatigue in RRMS

New Spinal Cord Lesions Can Be Evident in Stable MS Patients

Potential for Stem Cells to Repair Myelin Focus of University Toronto Team

Rituximab Effects Evident at Low Dose, Persist After Treatment Stops

Brain Changes in Relapsing MS Found to Follow Pattern

Compound That Mimics Thyroid Hormone Prevents MS Nerve Damage in Mice

Public-private Partnership Will Assess Therapy Potential, Effects of CBD

MS Patient-derived Stem Cells May Be Viable Source for Myelin Repair, Mouse Study Shows

MS-Specific Cognitive Rehabilitation Tool Shows Promise in Pilot Study

Non-invasive Imaging Technique Reveals Ibudilast’s Neuroprotective Effect

VX-765 Therapy, Given Through Nose, Limits MS Progression in Early Study

European Patent Given to IMP761, Antibody Aiming to Treat MS

Mayzent Approved for Active Secondary Progressive MS in Scotland

Aubagio’s Long-term Benefits Not Influenced by Prior Treatments, Review Finds

Children With MS Do Well at School Despite Challenges, Danish Study Finds

$373K Grant to Support Discovery of Remyelinating Compounds for MS

MS Patients Using Cooling Vests Show Significant Exercise Gains in Small Study

Subscribe to our newsletter